Benzinga | Nov 2, 2021 06:04PM EDT

Exact Sciences Q3 Adj. EPS $(0.79) Beats $(0.85) Estimate, Sales $456.38M Beat $430.03M Estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.85) by 7.06 percent. This is a 1028.57 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $456.38 million which beat the analyst consensus estimate of $430.03 million by 6.13 percent. This is a 11.76 percent increase over sales of $408.36 million the same period last year.